Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
about
Autoimmune Myopathies: Where Do We Stand?MDA5-positive dermatomyositis: an uncommon entity in Europe with variable clinical presentationsEvidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapyUbiquitin-like modifier FAT10 attenuates RIG-I mediated antiviral signaling by segregating activated RIG-I from its signaling platformDifferential roles of hypoxia and innate immunity in juvenile and adult dermatomyositisTranscriptomic profiling of long non-coding RNAs in dermatomyositis by microarray analysisDermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling.Treatment of Juvenile Dermatomyositis: An Update.IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis.Integrated classification of inflammatory myopathies.RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositisHypoxia triggers IFN-I production in muscle: Implications in dermatomyositis.Vascular changes and perifascicular muscle fiber damage in dermatomyositis: another question of the chicken or the egg that is on our mind.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis.Sustained autoimmune mechanisms in dermatomyositis.Expression of the OAS Gene Family Is Highly Modulated in Subjects Affected by Juvenile Dermatomyositis, Resembling an Immune Response to a dsRNA Virus Infection
P2860
Q26744554-503FCCCC-FF3B-4D04-A682-EE581F34B101Q26777975-C5F6EDDE-184C-447E-A223-46B11F6793C8Q35875974-4C4FC7D1-1483-4961-BA57-9AD3254D3B15Q36707766-AF8DFB23-0303-462B-BADB-B76C0F434160Q36842564-B463C022-2C39-416E-AE0F-64E0298C5B22Q37240008-8ADA7F9A-E8BC-4932-BAA2-72D19D1A83DFQ37463994-3299ACDB-F813-4A67-916C-B41AC7214FB5Q38678257-17E59ECB-F452-4B13-865D-DA2FDE22E263Q38721602-4052C40F-8AC3-4AA7-8416-3475833513E0Q39027323-DA1C62F3-D084-4A11-8B3B-6120FDFA011EQ41111946-321AEFC1-F543-4958-B94D-C063EE52AA96Q41447617-4019903D-0BA8-4C90-BA69-831E4F882B0EQ41832832-232F6827-9F2B-4857-9508-3932D5CD57FBQ42365042-91F7F067-8625-49B3-8C56-C4265516BFB9Q49897563-55B6D5D1-F8BC-4D68-BADC-ED309C94D978Q51549029-1423E88B-12EA-4EBB-BB8D-D05D9022B808Q52147259-7796BDD8-AA25-494F-9AD0-985BB265DD7FQ53059776-DF007081-8A4C-4370-A2E8-9F5DFCCA8019Q58730181-3D00E263-CBB9-487C-8EF4-0988ACD4B591
P2860
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
@en
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
@nl
type
label
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
@en
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
@nl
prefLabel
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
@en
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis.
@nl
P2860
P50
P356
P1476
Altered RIG-I/DDX58-mediated innate immunity in dermatomyositis
@en
P2093
Isabel Illa
Luis Querol
P2860
P304
P356
10.1002/PATH.4346
P577
2014-04-29T00:00:00Z